The serum alpha-synuclein levels in patients with multiple sclerosis need more evidence

J Neuroimmunol. 2021 Mar 15;352:577465. doi: 10.1016/j.jneuroim.2020.577465. Epub 2021 Jan 23.

Authors

Yin Niu¹, Yibo Li²

Affiliations

¹ The First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology, Luoyang, Henan 471003, China.
² Department of Pediatric Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. Electronic address: liyibo19@sina.cn.

PMID: 33493984
DOI: 10.1016/j.jneuroim.2020.577465

No abstract available

Keywords: Alpha-synuclein; Immunomodulation; Multiple sclerosis.

Publication types

Letter
Comment

MeSH terms

Humans
Multiple Sclerosis*
alpha-Synuclein*

Substances

alpha-Synuclein